Business Context and Reporting Period
Company: The Ensign Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2010
Business Overview: Ensign operates 81 skilled nursing and rehabilitative care facilities, plus two home health and hospice operations, across seven states (California, Arizona, Texas, Washington, Utah, Colorado, and Idaho). As of June 30, 2010, the company owned 51 facilities and leased 30, with a total capacity of approximately 9,344 operational beds. The company is a holding company with no direct operating assets; all operations are conducted through separate, wholly-owned subsidiaries.
Key Financial Metrics (Six Months Ended June 30, 2010)
| Metric | 2010 (YTD) | 2009 (YTD) |
|---|---|---|
| Revenue | $312.1 million | $262.5 million |
| Net Income | $19.0 million | $16.1 million |
| Diluted EPS | $0.90 | $0.77 |
| Operating Income | $35.8 million | $29.0 million |
| Operating Margin | 11.5% | 11.0% |
| Net Cash from Operating Activities | $14.9 million | $18.7 million |
| Cash and Cash Equivalents (End of Period) | $26.4 million | $33.7 million |
| Total Debt (Long-term + Current) | $108.5 million | $109.5 million |
| EBITDA | $43.8 million | $35.2 million |
| EBITDAR | $51.0 million | $42.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 18.9% year-over-year, driven primarily by the acquisition of five new facilities (four skilled nursing, one home health/hospice) totaling approximately $18.8 million in purchase price. Acquisitions contributed approximately $39.5 million to the revenue increase.
- Profitability: Net income increased 17.8% to $19.0 million. Operating margin improved slightly to 11.5% from 11.0%.
- Cost Structure: Cost of services increased 18.9% to $249.0 million, remaining consistent at 79.8% of revenue. General and administrative expenses rose 17.4% due to increased wages, benefits, and professional fees. Depreciation and amortization increased 29.2% due to new acquisitions and renovations.
- Cash Flow: Net cash provided by operating activities decreased $3.8 million to $14.9 million, primarily due to a $13.0 million increase in accounts receivable balances compared to $6.4 million in the prior year.
- Occupancy: Consolidated occupancy remained stable at 79.4% for the six months ended June 30, 2010, compared to 79.6% in the prior year. Recently acquired facilities operated at lower occupancy (71.8%), slightly dragging down the consolidated average.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Investigation: The company is subject to an ongoing investigation by the U.S. Attorney's Office and the Department of Justice regarding billing and reimbursement processes at certain facilities. Search warrants were served in 2008, and subpoenas were issued in 2009. The company has not been formally charged but notes that the outcome could materially affect financial condition. No accruals have been recorded for potential losses as the range cannot be estimated.
- Revenue Adjustment: In the quarter ended June 30, 2010, the company accrued a revenue adjustment of approximately $0.55 million (plus interest) related to estimated Medicare overpayments identified during an internal inquiry at one facility. This resulted in a net income impact of approximately $0.25 million.
- Acquisition Strategy: Management continues to pursue acquisitions of underperforming facilities to improve returns. The company anticipates that overall occupancy may vary quarter-to-quarter based on the maturity of newly acquired facilities.
- Legislative Risks: The Patient Protection and Affordable Care Act introduces new transparency requirements, potential payment suspensions during fraud investigations, and expanded False Claims Act liability. The company notes that future reimbursement rate changes or cost-containment measures could adversely affect operations.
- Liquidity: The company maintains a $50 million revolving credit facility (Revolver) with General Electric Capital Corporation, with no outstanding borrowings as of June 30, 2010. Management believes current cash balances and operating cash flow are sufficient for the next 12 months.
Investor Verification Checklist
- Regulatory Exposure: Verify the status of the U.S. Attorney's investigation and any potential financial impact from the DOJ search warrants and subpoenas.
- Acquisition Integration: Assess the performance and occupancy trends of the five facilities acquired in the first half of 2010, which currently operate at lower occupancy rates than the company average.
- Accounts Receivable: Monitor the $13.0 million increase in accounts receivable and its impact on future operating cash flows.
- Reimbursement Rates: Track changes in Medicare and Medicaid reimbursement rates, particularly in California and Texas, which represent a significant portion of revenue.
- Debt Covenants: Confirm continued compliance with debt covenants, specifically regarding occupancy and debt service coverage ratios, given the company's leverage and lease obligations.